Rationale and Design of a randomized,Double-Blind.Parallel-Group Study of Terutroban 30mg day versus Aspirin 100 mg.day in Stroke Patients:The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attak(Perform)Study
- Publication date
- 1 January 2009
- Publisher
